VSE Capital Markets

Sun Pharmaceuticals Industries Ltd

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE915.50 31.10 (3.52%)

PREV CLOSE (₹) 884.40

OPEN PRICE (₹) 885.80

BUY PRICEN/A

SELL PRICE N/A

VOLUME 294,992

TODAY'S RANGE (₹)917.00885.80

52 WK RANGE(₹)966.90652.75

NSE915.65 31.05 (3.51%)

PREV CLOSE( ₹ ) 884.60

OPEN PRICE (₹) 893.00

BUY PRICE 915.65(×380)

SELL PRICEN/A

VOLUME 2,877,917

TODAY'S RANGE(₹) 917.70889.05

52 WK RANGE (₹)967.05652.70

Stock Summary

MARKET CAP (₹ CR)	219,659.12
P/E	125.93
BOOK VALUE (₹)	113.47
DIV (%)	750.00
MARKET LOT	1.00

EPS (TTM)	7.27
PRICE/BOOK	8.07
DIV YIELD.(%)	0.82
FACE VALUE (₹)	1.00
DELIVERABLES (%)	81.41

Background Information

Incorporation Year	1993
Registered Office	Sun Pharma Advanced Res.Centre,Tandalja Vadodara,Gujarat-390020
Telephone	91-265-6615500,Managing Director
Fax	91-265-2354897
Chairman	Israel Makov
Managing Director	Dilip S Shanghvi
Company Secretary	Anoop Deshpande
Auditor	S R B C & Co LLP
Face Value	1
Market Lot	1
Listing	BSE,MSEI ,NSE,
Registrar	Link Intime India Pvt Ltd C-101 247 Park ,L B S Marg ,Vikhroli West ,Mumbai-400083

MF Holdings

Scheme Name	Hold(%)
ICICI Pru Value Discovery Fund	7.40
SBI ETF Nifty 50	1.34
SBI ETF SENSEX	1.56
SBI Equity Hybrid Fund	1.82
Mirae Asset Large Cap Fund	2.45

News & Announcements

Date	News
19-May-2022	Sun Pharmaceuticals Industries Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
18-May-2022	Sun Pharma to launch Bempedoic Acid under brand name Brillo®
18-May-2022	Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
16-May-2022	Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release

Share Holding

Peer Group

Cipla Ltd 978.60 ( 4.32)	M.Cap (₹ in Cr) 78954.82
Dr Reddys Laboratories Ltd 4246.30 ( 8.10)	M.Cap (₹ in Cr) 70669.49
Piramal Enterprises Ltd 1917.10 ( 1.19)	M.Cap (₹ in Cr) 45754.22
Torrent Pharmaceuticals Ltd 2664.45 ( 2.82)	M.Cap (₹ in Cr) 45087.82
Biocon Ltd 339.65 ( 5.17)	M.Cap (₹ in Cr) 40778.38

3rd Floor,Fortune Tower,Sayajigunj, Vadodara 390020, Gujarat, India

Telephone: +91 265 2361534

Customer Care Number: +91 265 2361474

Customer Care Timings: Monday to Friday 8:30am to 6:15pm

Email Address: vse@vselindia.com / compliance@vselindia.com

Attention Investors:

"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
KYC is one time exercise while dealing in securities market - once KYC is done through a SEBI registered intermediary (broker , DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

For any complaints pertaining to securities broking please write to compliance@vselindia.com, for DP related to dp@vselindia.com. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed.